3.2 ENG testing should be reserved
for the assessment of patients with vertigo, dizziness, or dysequilibrium and
who are suspected of suffering from the following vestibular system
abnormalities: The list of indications is not all inclusive. Other
indications are covered when documented by reliable evidence as
safe, effective, and comparable or superior to standard care (proven).
• Meniere’s disease/Endolymphatic
hydrops
• Vestibular neuritis
• Labyrinthine concussion
• Recurrent vestibulopathy
• Migraine-associated dizziness,
benign paroxysmal vertigo of childhood
• Labyrinthine ischemia
• Chemical-induced vestibulotoxicity